Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats. 2004

Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.

The present study was performed to examine the sedative effects of second-generation histamine H(1) receptor antagonist using power spectrum analysis in the rat. Similar to ketotifen, olopatadine caused a decrease in sleep latency at a dose of 50 mg/kg, while epinastine and cetirizine showed no significant effect even at a dose of 50 mg/kg. On the other hand, no significant difference was observed in the total times of wakefulness, non-rapid eye movement sleep and rapid eye movement sleep by any drugs used in the experiments. The number of sleep phases and interval between sleep phases were also unchanged by these drugs. Ketotifen and olopatadine inhibited [(3)H]mepyramine binding to rat brain homogenates in parallel with a decrease in sleep latency. No significant effect was observed with epinastine and cetirizine on [(3)H]mepyramine binding. These findings suggest that the differences in the central nervous system (CNS) depressant effect observed in second generation H(1) receptor antagonists may be due to their liability to penetrate into the CNS.

UI MeSH Term Description Entries
D008297 Male Males
D011738 Pyrilamine A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies. Mepyramine,Pyranisamine,Anthisan,Boots Bite & Sting Relief,Kriptin,Mepyramine Maleate,Pyrilamine Maleate,Maleate, Mepyramine,Maleate, Pyrilamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D014851 Wakefulness A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli. Wakefulnesses

Related Publications

Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
January 2003, Clinical and experimental pharmacology & physiology,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
January 1986, Journal of neural transmission,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
January 1991, Annals of allergy,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
February 2007, Journal of pharmacological sciences,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
May 2004, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
May 2012, European journal of pharmacology,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
June 1994, Agents and actions,
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
September 2005, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
January 1993, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Yuki Shigemoto, and Kazuaki Shinomiya, and Mitsunobu Mio, and Nobuhide Azuma, and Chiaki Kamei
January 2019, BioMed research international,
Copied contents to your clipboard!